mNGS for IPA
Invasive pulmonary aspergillosis (IPA), traditionally associated with severe immunocompromise, has increasingly been reported in immunocompetent patients, where delayed recognition and distinct pulmonary microbiota complicate timely diagnosis and antibiotic selection, leading to higher mortality.